UNKNOWN IMPLANTABLE NEUROSTIMULATOR NEU_INS_STIMULATOR

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,literatur report with the FDA on 2017-01-31 for UNKNOWN IMPLANTABLE NEUROSTIMULATOR NEU_INS_STIMULATOR manufactured by Medtronic Neuromodulation.

Event Text Entries

[66170516] Pt age: please note that this age is the average age of the patients reported in the article, as the actual age of patients involved was not provided. Pt gender: please note that this is the gender of the majority of patients reported in the article as the actual genders of patients involved was not provided. Date of event: please note that this date is based off the date of publication of the article as the actual event date was not provided. Concomitant medical products: product id neu_ins_stimulator, product type implantable neurostimulator, quantiy: 16. A good faith effort will be made to obtain the applicable information relevant to the report. If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


[66170517] Fayad sm, guzick ag, reid am, mason dm, bertone a, foote kd, okun ms, goodman wk, ward he. Six-nine year follow-up of deep brain stimulation for obsessive-compulsive disorder. Plos one. 2016; 11(12): e0167875 doi: 10. 1371/journal. Pone. 0167875. Summary: deep brain stimulation (dbs) of the ventral capsule/ventral striatum (vc/vs) region has shown promise as a neurological intervention for adults with severe treatment-refractory obsessive-compulsive disorder (ocd). Pilot studies have revealed improvement in obsessive-compulsive symptoms and secondary outcomes following dbs. We sought to establish the long-term safety and effectiveness of dbs of the vc/vs for adults with ocd. Reported event: 1 patient with bilateral deep brain stimulation (dbs) for obsessive-compulsive disorder (ocd) experienced a serious adverse event. The patient was admitted to an inpatient psychiatric facility following a dbs settings adjustment within the first year post-implantation for worsening ocd. Once the settings were appropriately readjusted, the patient improved and was discharged. There was no specific device information provided.
Patient Sequence No: 1, Text Type: D, B5


[99020086] A good faith effort will be made to obtain the applicable information relevant to the report. If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3007566237-2017-00397
MDR Report Key6290125
Report SourceHEALTH PROFESSIONAL,LITERATUR
Date Received2017-01-31
Date of Report2017-01-31
Date of Event2016-12-08
Date Mfgr Received2017-01-12
Date Added to Maude2017-01-31
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactLISA CLARK
Manufacturer Street7000 CENTRAL AVENUE NE RCW215
Manufacturer CityMINNEAPOLIS MN 55432
Manufacturer CountryUS
Manufacturer Postal55432
Manufacturer Phone7635263920
Manufacturer G1MEDTRONIC NEUROMODULATION
Manufacturer Street800 53RD AVE NE
Manufacturer CityMINNEAPOLIS MN 554211200
Manufacturer CountryUS
Manufacturer Postal Code554211200
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameUNKNOWN IMPLANTABLE NEUROSTIMULATOR
Generic NameIMPLANTED SUBCORTICAL ELECTRICAL STIMULATOR (MOTOR DISORDERS)
Product CodeMFR
Date Received2017-01-31
Model NumberNEU_INS_STIMULATOR
Catalog NumberNEU_INS_STIMULATOR
Lot NumberUNKNOWN
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerMEDTRONIC NEUROMODULATION
Manufacturer Address800 53RD AVE NE MINNEAPOLIS MN 554211200 US 554211200


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization 2017-01-31

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.